Form 4: CareDx CEO Sells Shares Under Pre-Arranged 10b5-1 Plan

CareDx Inc. President and CEO John Walter Hanna Jr. sold common stock totaling 19,480 shares in January 2026 under a pre-arranged Rule 10b5-1 trading plan.

Summary

• John Walter Hanna Jr., President and CEO of CareDx, Inc. and a Director, reported transactions involving the sale of common stock.
• On January 21, 2026, 200 shares of common stock were sold at a price of $21 per share.
• On January 22, 2026, 19,280 shares of common stock were sold at a weighted average price of $21.163 per share, with prices ranging from $21.00 to $21.43.
• These sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hanna on December 13, 2024.
• Following these transactions, Mr. Hanna beneficially owns 597,405 shares of CareDx common stock.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, but mitigated by the fact that the sales were pre-planned under a Rule 10b5-1 plan, which suggests a scheduled liquidity event rather than a reaction to new negative information.

Positives

• The sales were conducted under a Rule 10b5-1 trading plan, which provides an affirmative defense against insider trading allegations by pre-scheduling transactions, demonstrating adherence to corporate governance best practices.

Negatives

• Insider selling, even when pre-planned, can sometimes be perceived negatively by investors as it reduces management's direct equity stake in the company.

Risks

• The sale of shares by a key executive could be interpreted by some investors as a lack of confidence in the company's near-term prospects, potentially leading to downward pressure on the stock price.

Management Comments

• The reporting person undertakes to provide full information regarding the number of shares sold at each separate price within the reported range upon request from the Issuer, any security holder, or the SEC staff.

Industry Context

This filing is specific to an individual executive's stock transactions and does not directly provide broader industry trends or competitive insights. However, insider trading activity is a common data point monitored by analysts across all industries.

Corporate Governance

Related Party Transactions

• The transactions involve the sale of common stock by a key executive (President and CEO) to the public market, which is a common type of insider transaction.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a signal, potentially influencing their investment decisions, though the 10b5-1 plan context often lessens the impact.
• Employees: No direct impact mentioned, but general market perception can indirectly affect employee morale or stock-based compensation value.

Key Dates

Recommendation

The insider sales by the CEO were conducted under a pre-arranged Rule 10b5-1 trading plan, adopted over a year prior to the transactions. This indicates a planned liquidity event rather than a reaction to new, adverse company-specific information. While insider selling can be a negative signal, the pre-planned nature mitigates its impact on the company's fundamental outlook. Therefore, a 'hold' recommendation is appropriate, as this event alone does not fundamentally alter the investment thesis for CareDx, Inc.

Keywords

CareDx, CDNA, Insider Trading, Form 4, Stock Sale, 10b5-1 Plan, CEO, Beneficial Ownership